ConductScience.org, home
ALDH7A1: aldehyde dehydrogenase 7 family member A1
API referenceFor AI assistants

Gene · 501

Papers3,847

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

41 to 60 of 3,847

Download this page as JSON
TitleJournalYearPMIDFound bySource
Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties.Cell Death Discov202641851107PubTator, text miningPubMed
Lysine attenuates acute lung injury by restoring α-tubulin acetylation and ciliary activity.Cell Death Discov202641839843PubTator, text miningPubMed
[Scientific connotation of Jianpi Huogu Formula in treating steroid-induced ONFH based on lipid metabolism reprogramming and transcriptional regulatory network].Zhongguo Zhong Yao Za Zhi202641814721PubTator, text miningPubMed
Genetic spectrum of unexplained neonatal seizures: a single-center study.Transl Pediatr202641810174PubTator, text miningPubMed
A rare fungal threat: Successful management of pan-drug resistant Microascus cirrosus peritonitis in a PD patient.IDCases202641810087PubTator, text miningPubMed
A variational framework for residual-based adaptivity in neural PDE solvers and operator learning.NPJ Artif Intell202641804505PubTator, text miningPubMed
Clinical and Functional Characterization of PDE1A as a Wnt/β-Catenin-Linked Biomarker of Progression and Platinum Resistance in Epithelial Ovarian Cancer.Oncol Res202641799512PubTator, text miningPubMed
L-2-aminoadipic acid inhibits porcine epidemic diarrhea virus replication by targeting and reducing cellular autophagy.Vet Microbiol202641793871PubTator, text miningPubMed
Biological implications and therapeutic potential of phosphodiesterase inhibitors: A review.Medicine (Baltimore)202641790675PubTator, text miningPubMed
A novel therapy for pyridoxine-dependent epilepsy due to biallelic pathogenic variants in ALDH7A1: secondary mitochondrial energy deficiency and improvements of neurodevelopmental outcomes on triheptanoin treatment.
Ther Adv Rare Dis202641789364PubTator, text miningPubMed
Analysis of treatment outcome variations in infantile epileptic spasms syndrome.Front Neurol202641783846PubTator, text miningPubMed
Implicit quiescent soliton perturbation in optical metamaterials with complex Ginzburg-Landau equation having nonlinear chromatic dispersion and Kudryashov's forms of self-phase modulation structures by lie symmetry.
MethodsX202641783247PubTator, text miningPubMed
Emerging roles of RNA N5-methylcytosine modification in reproductive physiology and gynecological diseases.Epigenetics202641778387PubTator, text miningPubMed
Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening.Sci Rep202641775739PubTator, text miningPubMed
Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancer.Signal Transduct Target Ther202641775684PubTator, text miningPubMed
Underrepresentation of Women in COPD Pharmacologic Trials Relative to Disease Burden: A Systematic Review and Meta-Analysis.Int J Chron Obstruct Pulmon Dis202641773232PubTator, text miningPubMed
Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies.Front Pharmacol202641769701PubTator, text miningPubMed
Vem++, a C++ library to handle and play with the virtual element method.Numer Algorithms202641767826PubTator, text miningPubMed
Recording interventionalists' occupational dose by clinical procedure: a novel approach to radiation safety.CVIR Endovasc202641762425PubTator, text miningPubMed
Reversing Mitochondrial Dysfunction in Optineurin E50K Glaucoma: A Metabolic Approach to Neuroprotection.Res Sq202641756461PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/501/papers?page=3

API referenceFor AI assistants